August 14, 2025

Dalbavancin Holds Its Own Against S. aureus Bacteremia, Study

"All treatments currently approved with an indication for bacteremia require prolonged intravenous access."

Conexiant

August 11, 2025

FDA Grants Priority Review to Gepotidacin for Gonorrhea

First potential oral treatment for gonorrhea supported by positive phase 3 trial results.

Conexiant

August 07, 2025

Metagenomics Reshapes Intensive Care Units

UK hospitals are using real-time sequencing to detect infections faster, improve patient outcomes, and support national surveillance

The Pathologist

July 24, 2025

Penicillin Allergy Label? Or Antibiotic Overuse?

Structured testing in primary care boosted penicillin prescribing fivefold, lowered overall antibiotic use, and proved cost-effective.

Conexiant

July 23, 2025

IDSA Issues Stratified Antibiotic Approach for complicated UTIs

New recommendations outline a stratified antibiotic treatment for complicated urinary tract infections, including shorter durations, oral transition timing, and tailored empiric choices based on illness severity and resistance risks.

Conexiant

July 21, 2025

Stanford Physician-Scientist Takes CDER Helm

Stanford's George Tidmarsh appointed FDA's new CDER director, bringing 30+ years biotechnology experience and seven approved drugs.

Conexiant

June 17, 2025

FMT as First-Line CDI Treatment?

New randomized trial shows fecal microbiota transplantation may reduce antibiotic dependence in first-episode infections

Conexiant

June 18, 2025

Are CBD Compounds Effective Antifungals?

CBD and CBDV exhibit antifungal activity against Cryptococcus neoformans and dermatophytes in vitro and improve survival in an in vivo model.

Conexiant

June 24, 2025

Shorter Antibiotic Courses: Safe for DFO?

A new meta-analysis aims to clarify optimal antibiotic duration for diabetic foot osteomyelitis

Conexiant